查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2129058

GMP質體DNA生產市場：依產品、應用、類型、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

GMP Plasmid DNA Manufacturing Market, By Product, By Application, By Type, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 350 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，GMP質體DNA 生產市場價值將達到 2.7865 億美元，並將在 2026 年至 2033 年以 9.5% 的複合年成長率成長。

GMP質體DNA生產是指依照良好生產規範（GMP）生產質體DNA，以確保臨床試驗和商業生物製藥應用所需的質粒DNA生產的一致性、可控制性和可記錄性。該過程通常包括質體設計和製備、微生物發酵、質體提取、純化、濃縮、無菌過濾和品管檢測。 GMP生產涉及對原料、環境、設備、人員和工藝的全面控制，以防止污染並確保成品的品質、純度、鑑別、有效性和安全性。 GMP級質體DNA常被用作基因治療、DNA疫苗、細胞療法和其他生物製藥的主要起始原料或藥物成分。

GMP質體DNA生產市場－市場動態

臨床試驗數量的增加正在推動市場需求。

基因療法、細胞療法、疫苗和其他先進藥物的臨床試驗數量不斷增加，推動了對符合GMP標準的質體DNA的需求。這是因為處於臨床階段的研發公司需要高品質、受監管的DNA來合成病毒載體和其他治療應用。 2025年的一項產品上市便是這一趨勢的例證。具體而言，ProBio將於2025年4月在其位於新澤西州霍普韋爾的工廠推出符合GMP標準的質體DNA生產服務，提供臨床級質體DNA，目標交付週期約為三個月（從細胞庫到批次放行）。該公司專門設計了這項服務，旨在加速基因療法和細胞療法的臨床計畫。

同樣，Aldevron將於2025年7月推出小規模GMP（ssGMP）質體DNA服務，供應量為1毫克至500毫克。這項服務非常適合早期臨床項目，例如小規模患者隊列試驗、AAV和慢病毒載體生產、基於CRISPR的基因編輯以及轉座子療法。這些服務的推出很好地體現了臨床試驗活性化如何推動柔軟性的小規模GMP生產以及大規模商業化GMP質體生產的發展，並最終推動GMP質體DNA生產業務的成長。

GMP質體DNA生產市場－市場區隔分析：

全球GMP質體DNA生產市場按產品、應用、類型和地區進行細分。

依產品類型，市場可分為七大類：質體DNA、病毒載體、非病毒載體、電穿孔載體、脂質/聚合物載體、奈米顆粒載體及其他載體。質體DNA載體是推動市場成長的主要動力。這一成長主要得益於越來越多的先進治療計畫從研究和臨床前階段進入臨床和商業化生產階段。相關企業致力於擴大生產規模，同時確保核酸產品的品質。因此，越來越多的製藥和生物技術公司尋求生產更高純度的GMP級質體DNA，也促進了該市場的成長。

此外，病毒載體生產（包括AAV和慢病毒等平台）的擴張進一步推動了需求，因為質體DNA在過程中被頻繁使用。支持質體DNA生產領域成長的另一個因素是企業在各領域對研發的投入。例如，領先的質體DNA生產商之一Aldevron宣布，已生產超過16.5萬批次的質體，其中約5,000批次為臨床級。這些質粒共同支持處於臨床試驗階段或已商業化的細胞療法、基因療法和mRNA療法計畫。因此，預計這一趨勢將推動GMP質體DNA生產市場的成長。這些產品的推出表明，臨床試驗活動的活性化不僅推動了對大規模商業化GMP質體生產的需求，也推動了對靈活的小批量GMP生產的需求，從而促進了GMP質體DNA生產行業的成長。

根據應用領域，市場可分為四大類：DNA疫苗、免疫療法、基因療法和其他。 DNA疫苗佔據市場主導地位，預計在預測期內將保持其領先地位。市場成長的主要驅動力是DNA疫苗研發的不斷深入，尤其是針對感染疾病和癌症的DNA疫苗。隨著DNA疫苗候選產品進入臨床試驗階段，生產商需要符合GMP標準的高純度、高均一性和符合法規要求的質體DNA，這推動了對專業質體生產服務的需求。與DNA質體疫苗研發相關的研究是整個質體DNA生產市場的關鍵促進因素。

GMP質體DNA生產市場－區域分析

北美在市場佔有率方面佔據主導地位。政府投資在支持這一成長方面發揮著至關重要的作用。 2025會計年度，美國國立衛生研究院（NIH）報告的總經費約為485億美元。在2025會計年度，NIH報告的競爭性和非競爭性外部研究津貼總額為353億美元。這些津貼有助於維持生物醫學研究生態系統，這是先進候選療法和臨床計畫的來源，並間接推動了藥物進入臨床開發階段對符合GMP標準的質體DNA的需求。

政府資金也透過支持生物製造基礎設施來扶持先進細胞療法生產商。美國商務部宣布，美國國家標準與技術研究院 (NIST) 將向「美國製造」網路提供 3,700 萬美元的資金，其中包括每年向國家生物製藥製造創新研究所 (NIIMBL) 撥款 1,400 萬美元。美國能源部 (DOE) 則透過加速國內生物製造研發和規模化生產活動來支持先進細胞療法生產商。

市場需求不斷成長，業內相關人員正加大對生產設施建設的投資。例如，ProBio公司於2025年6月宣布，將在新澤西州霍普韋爾市建造一座佔地12.8萬平方英尺、符合GMP標準的質體DNA和病毒載體生產設施。該公司旨在透過提升細胞和基因治療生產商的產能，滿足日益成長的病毒載體需求。因此，除了對GMP生產設施的投資外，生物製藥領域研發投入的增加、政府主導的生物醫學研究以及臨床管線的拓展，預計也將推動北美GMP質體DNA生產市場的收入成長。

美國GMP質體DNA生產市場—國家分析

美國佔最大的市場佔有率。推動這一成長的關鍵因素是市場領導者之間日益密切的合作，這擴大了質體DNA在下游治療藥物生產中的應用。 2025年5月，瓦克生物技術美國公司（Wacker Biotech US）與Expression Manufacturing公司達成策略合作，旨在加速基於慢病毒的基因和細胞療法的開發和生產。瓦克生物技術將提供PLASMITEC®質體DNA平台，該平台具有超過90%的超螺旋pDNA，而Expression Manufacturing公司將提供病毒載體技術。該協議將提供從GMP質體原料到病毒載體生產的全面解決方案，隨著基因和細胞療法研究的不斷深入，質體DNA的潛在市場也將隨之擴大。

目錄

第1章：GMP質體DNA生產市場概覽

  • 調查範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：GMP質體DNA生產的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：GMP質體DNA生產的工業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：GMP質體DNA生產市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：GMP質體DNA生產的市場趨勢

  • 2025年GMP質體DNA生產市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 GMP質體DNA生產市場：依產品分類

  • 概述
    • 基於細分市場的市佔率分析：按產品
    • 質體DNA
    • 病毒載體
      • 逆轉錄病毒
      • 腺病毒
      • 慢病毒
      • 腺結合病毒
      • 其他
    • 非病毒
    • 電穿孔
    • 脂質/聚合物
    • 奈米顆粒
    • 其他

第8章 GMP質體DNA生產市場：依應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • DNA疫苗
    • 免疫療法
    • 基因治療
    • 其他

第9章 GMP質體DNA生產市場：按類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類型
    • 臨床前治療
    • 臨床給藥藥物
    • 非處方藥

第10章：GMP質體DNA生產市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第11章：主要供應商分析：GMP質體DNA生產產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Weisman Biomanufacturing
    • Wuxi Advanced Therapies
    • Rescript Probe
    • Cobra Bio
    • Charles River
    • Thermo Fisher Scientific
    • Bioscience
    • Lake Pharma
    • Alderton
    • Kaneka Neurogenetic SA
    • Catalent Biologics
    • Neurogenetic
    • Nature Technology Corporation
    • Plasmid Factory
    • VGXI, Inc.
    • Vector Builder
    • Delphi Genetics
    • Esko Aster
    • Bionian
    • Creative Biolabs
    • Cognate Bio Services
    • Patheon
    • Vilene Biosciences
    • 其他

第12章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7334

GMP Plasmid DNA Manufacturing Market size was valued at US$ 278.65 Million in 2025, expanding at a CAGR of 9.5% from 2026 to 2033.

GMP Plasmid DNA Manufacturing is the creation of plasmid DNA in accordance with good manufacturing practice to provide consistent production, control and documentation for clinical trial and commercial biopharmaceutical applications. The procedure generally includes plasmid design/preparation, microbial fermentation, plasmid extraction, purification, concentration, sterile filtration and quality-controlled testing. GMP manufacturing involves complete control of materials, environment, equipment, personnel and process to prevent contamination and to ensure quality, purity, identity, potency and safety of the finished product. GMP-grade plasmid DNA is frequently employed as a key starting material or pharmaceutical ingredient in gene treatments, DNA vaccines, cell therapies and other biotherapeutics.

GMP Plasmid DNA Manufacturing Market- Market Dynamics

Rising number of clinical trials to propel market demand

The increasing number of clinical trials for gene therapies, cell therapies, vaccines and other advanced medicines are driving demand for GMP plasmid DNA as clinical-stage developers need high-quality, regulatory-compliant DNA for viral-vector synthesis and other therapeutic uses. The product launches in 2025 are an example of this tendency. Specifically, in April 2025, ProBio initiated its GMP plasmid DNA manufacturing service at its Hopewell, New Jersey plant, offering clinical-grade plasmid DNA with a targeted delivery timetable of about three months from cell bank to batch release. The company has specifically designed the service to accelerate clinical programs for gene and cell therapies.

Similarly, Aldevron launched its small-scale GMP (ssGMP) plasmid DNA service in July 2025, providing 1 mg to 500 mg quantities that are ideal for early-phase clinical programs such as small patient cohort trials, AAV and lentiviral vector manufacturing, CRISPR-based editing of genes, and transposon therapies. These launches are examples of how the increasing activity in clinical trials is increasing the demand not only for large scale commercial GMP plasmid production but also for flexible smaller volume GMP manufacturing, thus driving the growth of the GMP plasmid DNA manufacturing business.

GMP Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global GMP Plasmid DNA Manufacturing Market is segmented on the basis of Product, Application, Type, and Region.

The market is divided into seven categories based on product: Plasmid DNA, Viral Vectors, Non-viral, Electroporation, Lipid/polymer, Nanoparticles and Others. The Plasmid DNA segment dominates the market. The growth is assisted by the rising number of advanced-therapy programs, which are entering clinical and commercial manufacturing from research and preclinical stages. The companies involved are looking to scale their production, while ensuring the quality of the nucleic acid-based products. Thus, the rising number of pharmaceutical and biotech firms, which are looking to manufacture more high-purity, GMP-grade plasmid DNA, also contributes to the growth of this market.

Moreover, the expansion of viral-vector manufacturing, including such platforms as AAV or lentiviral, is further driving the need for plasmid DNA, as they are often used as part of the process. One more factor which supports the growth of the plasmid DNA manufacturing segment is the companies' investments in the research and development of various fields. For instance, one of the leading manufacturers of plasmid DNA, Aldevron, has announced that it has manufactured more than 165,000 plasmid lots, of which approximately 5,000 are clinical-grade lots. Altogether, they support cell, gene, and mRNA therapy programs, which are either in the clinical trial phases or have been commercialized. Therefore, this trend is expected to support the growth of the GMP plasmid DNA manufacturing market. These launches exemplify that the growing activity in clinical trials is raising the demand not only for large-scale commercial GMP plasmid production but also for flexible, smaller-volume GMP manufacturing, thus fueling the growth of the GMP plasmid DNA manufacturing industry.

The market is divided into four categories based on application: DNA Vaccines, Immunotherapy, Gene Therapy and Others. The DNA Vaccines dominate the market and is likely to maintain its dominance during the forecast period. The main reason behind the growth of the market is the increasing research and clinical development of DNA vaccines, especially for infectious diseases, and cancer. As DNA-vaccine candidates are advancing toward clinical trials, manufacturers are in need of GMP-grade plasmid DNA with high purity, consistency, and regulatory compliance, which increases the demand for specialized plasmid manufacturing services. The research on DNA-plasmid vaccine development is a significant factor supporting the overall plasmid DNA manufacturing market.

GMP Plasmid DNA Manufacturing Market- Geographical Insights

North America holds a prominent market share. Government investment is playing a crucial role in backing such growth. In FY2025, the U.S. National Institutes of Health (NIH) reported a total of about US$48.5 billion. In FY2025, NIH reported US$35.3 billion for competing and noncompeting extramural research awards. These grants help sustain the biomedical research ecosystem that supplies the source of advanced-therapy candidates and clinical programs, which indirectly drives demand for GMP plasmid DNA as medicines enter the clinical development stage.

Government funding also assists advanced cell therapy producers by supporting biomanufacturing infrastructure. The U.S. Department of Commerce announced the Manufacturing USA network financing of US$ 37 million by NIST, including the US$ 14 million yearly allocation for the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). The Department of Energy (DOE) sponsored Advanced Cell Therapy manufacturers by fostering domestic biomanufacturing R&D and scale-up activities.

The demand is growing, and industry participants are increasing the investment in the construction of production facilities. For instance, ProBio announced in June 2025 that it would build a 128,000-square-foot GMP plasmid DNA and viral-vector production facility in Hopewell, N.J. The company hopes to satisfy the growing demand for viral vectors by boosting the capacities in the production of cell and gene therapy manufacturers. Hence, the investments in GMP manufacturing facilities along with increasing R&D spending in the biopharmaceutical sector, government-sponsored biomedical research, and augmented clinical pipeline would drive the revenue growth of the GMP plasmid DNA manufacturing market in North America.

US GMP Plasmid DNA Manufacturing Market- Country Insights

The US Capture the largest market share. The major driver driving this growth is the increasing collaborations among the key players in the market, which is increasing the utilization of plasmid DNA for downstream therapeutic manufacture. In May 2025, Wacker Biotech US and Expression Manufacturing forged a strategic relationship to fast-track the development and manufacturing of lentiviral-based gene and cell therapies. Wacker brings their PLASMITEC(R) plasmid DNA platform that features >90% supercoiled pDNA while Expression Manufacturing offers the viral-vector technology. The agreement provides a complete solution from GMP plasmid starting materials to viral-vector production and expands the potential market for plasmid DNA as more gene and cell therapy studies are initiated.

GMP Plasmid DNA Manufacturing Market- Competitive Landscape:

The GMP plasmid DNA manufacturing market is moderately consolidated and competitive, with key CDMOs and plasmid-specific manufacturers vying to secure the majority of the demand by capitalizing on capabilities such as GMP manufacturing capacity, advanced purification technologies, regulatory know-how, turnaround time, scalability, and an ability to offer integrated cell- and gene-therapy services. The key market participants include Aldevron (Danaher), Charles River Laboratories, Thermo Fisher Scientific, Lonza, GenScript ProBio, VGXI, Catalent, AGC Biologics, Kaneka Eurogentec, PlasmidFactory, and WuXi Advanced Therapies. The competition is expected to intensify on the back of an increasing number of players offering end-to-end manufacturing services, which incorporate both plasmid DNA and viral-vector manufacturing and provide comprehensive cell- and gene-therapy solutions to meet the demands of customers at various stages of research and commercialization.

Recent Developments:

In August 2025, Bionova Scientific (Bionova), a biologics contract development and manufacturing organization (CDMO) and a subsidiary of Asahi Kasei, announced that it has opened a new 10,000-square-foot development and production facility for plasmid DNA (pDNA) in The Woodlands, Texas. The launch of this new facility marks a strategic expansion for the pharmaceutical industry, strengthening the US supply chain for advanced therapeutics. The site will design, develop, and produce research-grade pDNA materials to support the growing cell and gene therapy (CGT) sector.

In August 2025, WACKER and Gearbox Biosciences announced strategic collaboration to advance plasmid DNA manufacturing technologies. The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP PLASMID DNA MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Weisman Biomanufacturing
  • Wuxi Advanced Therapies
  • Rescript Probe
  • Cobra Bio
  • Charles River
  • Thermo Fisher Scientific
  • Bioscience
  • Lake Pharma
  • Alderton
  • Kaneka Neurogenetic S.A.
  • Catalent Biologics
  • Neurogenetic
  • Nature Technology Corporation
  • Plasmid Factory
  • VGXI, Inc.
  • Vector Builder
  • Delphi Genetics
  • Esko Aster
  • Bionian
  • Creative Biolabs
  • Cognate Bio Services
  • Patheon
  • Vilene Biosciences
  • Others

GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Plasmid DNA
  • Viral Vectors
  • Retroviral
  • Adenoviral
  • Lentiviral
  • Adeno-Associated
  • Others
  • Non-viral
  • Electroporation
  • Lipid/polymer
  • Nanoparticles
  • Others

GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • DNA Vaccines
  • Immunotherapy
  • Gene Therapy
  • Others

GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Pre-Clinical Therapeutics
  • Clinical Therapeutics
  • Marketed Therapeutics

GLOBAL GMP PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. GMP Plasmid DNA Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. GMP Plasmid DNA Manufacturing Market Snippet by Product
    • 2.1.2. GMP Plasmid DNA Manufacturing Market Snippet by Application
    • 2.1.3. GMP Plasmid DNA Manufacturing Market Snippet by Type
    • 2.1.4. GMP Plasmid DNA Manufacturing Market Snippet by Country
    • 2.1.5. GMP Plasmid DNA Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. GMP Plasmid DNA Manufacturing Key Market Trends

  • 3.1. GMP Plasmid DNA Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. GMP Plasmid DNA Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. GMP Plasmid DNA Manufacturing Market Opportunities
  • 3.4. GMP Plasmid DNA Manufacturing Market Future Trends

4. GMP Plasmid DNA Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. GMP Plasmid DNA Manufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. GMP Plasmid DNA Manufacturing Market Landscape

  • 6.1. GMP Plasmid DNA Manufacturing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. GMP Plasmid DNA Manufacturing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. Plasmid DNA
    • 7.1.3. Viral Vectors
      • 7.1.3.1. Retroviral
      • 7.1.3.2. Adenoviral
      • 7.1.3.3. Lentiviral
      • 7.1.3.4. Adeno-Associated
      • 7.1.3.5. Others
    • 7.1.4. Non-viral
    • 7.1.5. Electroporation
    • 7.1.6. Lipid/polymer
    • 7.1.7. Nanoparticles
    • 7.1.8. Others

8. GMP Plasmid DNA Manufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. DNA Vaccines
    • 8.1.3. Immunotherapy
    • 8.1.4. Gene Therapy
    • 8.1.5. Others

9. GMP Plasmid DNA Manufacturing Market - By Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 9.1.2. Pre-Clinical Therapeutics
    • 9.1.3. Clinical Therapeutics
    • 9.1.4. Marketed Therapeutics

10. GMP Plasmid DNA Manufacturing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. GMP Plasmid DNA Manufacturing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.16. Denmark
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.16.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.16.5. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.3.17. Rest of Europe
      • 10.3.17.1. Overview
      • 10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.3.17.5. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.15. Taiwan
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.15.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.15.5. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.16. Vietnam
      • 10.4.16.1. Overview
      • 10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.16.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.16.5. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.4.17. Rest of APAC
      • 10.4.17.1. Overview
      • 10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.4.17.5. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. GMP Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.13. Iran
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.13.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.13.5. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.14. Qatar
      • 10.6.14.1. Overview
      • 10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.14.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.14.5. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 10.6.15. Rest of MEA
      • 10.6.15.1. Overview
      • 10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 10.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 10.6.15.5. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)

11. Key Vendor Analysis- GMP Plasmid DNA Manufacturing Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Weisman Biomanufacturing
    • 11.2.2. Wuxi Advanced Therapies
    • 11.2.3. Rescript Probe
    • 11.2.4. Cobra Bio
    • 11.2.5. Charles River
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. Bioscience
    • 11.2.8. Lake Pharma
    • 11.2.9. Alderton
    • 11.2.10. Kaneka Neurogenetic S.A.
    • 11.2.11. Catalent Biologics
    • 11.2.12. Neurogenetic
    • 11.2.13. Nature Technology Corporation
    • 11.2.14. Plasmid Factory
    • 11.2.15. VGXI, Inc.
    • 11.2.16. Vector Builder
    • 11.2.17. Delphi Genetics
    • 11.2.18. Esko Aster
    • 11.2.19. Bionian
    • 11.2.20. Creative Biolabs
    • 11.2.21. Cognate Bio Services
    • 11.2.22. Patheon
    • 11.2.23. Vilene Biosciences
    • 11.2.24. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us